-
DEVELOPING A STRUCTURED CHECKLIST FOR EVALUATING TRANSITIVITY IN NETWORK META-ANALYSES
Aug 11, 2026, 17:15 PM -
PILOT EVALUATION OF AN AUTOMATED GDP-ADJUSTED HEALTHCARE COST TRANSFER FRAMEWORK FOR CROSS-COUNTRY COST ESTIMATION IN DATA-SCARCE MENA SETTINGS
Aug 11, 2026, 17:15 PM -
PRACTICAL CHALLENGES IN THE IMPLEMENTATION OF ML-NMR FOR RATE OUTCOMES: LESSONS FROM A RECENT EUROPEAN HTA SUBMISSION
Aug 11, 2026, 17:15 PM -
A DEDUCTIVE LARGE LANGUAGE MODEL (LLM) WORKFLOW FOR MULTI-TOPIC EVIDENCE LANDSCAPE MAPPING AT SCALE
Aug 11, 2026, 17:15 PM -
VIRTUAL PK/PD MODELING OF BIOMARKER GUIDED ELRANATAMAB RESPONSE PREDICTION
Aug 11, 2026, 17:15 PM -
ECONOMIC EVALUATION OF MULTICOMPONENT COMMUNICATION TRAINING FOR DEPRESCRIBING CARDIOMETABOLIC MEDICATION IN DUTCH OLDER ADULTS :THE CO-DEPRESCRIBE TRIAL
Aug 11, 2026, 17:15 PM -
TKIS IN THE FIRST LINE OF CHRONIC MYELOID LEUKEMIA. COST OF ADVERSE EVENTS IN SPAIN
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS OF A STRUCTURED LIFESTYLE INTERVENTION FOR TYPE 2 DIABETES PREVENTION IN PRIMARY CARE IN SPAIN
Aug 11, 2026, 17:15 PM -
TOWARDS MEANINGFUL OUTCOME MEASURES FOR HEALTH ECONOMIC EVALUATIONS IN SKIN CANCER
Aug 11, 2026, 17:15 PM -
DISCRETE EVENT SIMULATION OF CHRONIC KIDNEY DISEASE IN THE USA
Aug 11, 2026, 17:15 PM -
PHARMACOVIGILANCE STUDY OF FARICIMAB, AFLIBERCEPT, AND RANIBIZUMAB IN NAMD AND DME: FAERS-BASED INSIGHTS ON OCULAR ADVERSE EVENTS
Aug 11, 2026, 17:15 PM -
TRUST-MM | TRANSLATING US REAL-WORLD DATA TO UK CLINICAL PRACTICE: TREATMENT PATTERNS AND OUTCOMES IN FIRST LINE RELAPSED/REFRACTORY MULTIPLE MYELOMA
Aug 11, 2026, 17:15 PM -
NETWORK META-ANALYSIS (NMA) OF NEOADJUVANT-ADJUVANT TREATMENT PATHWAYS IN HER2+ EARLY BREAST CANCER (EBC) TO INFORM COST-EFFECTIVENESS
Aug 11, 2026, 17:15 PM -
ORAL ANTICOAGULATION PROGRAM REDUCES VENOUS THROMBOEMBOLISM IN PATIENTS RECEIVING FIRST-LINE CHEMOTHERAPY FOR OVARIAN CANCER: A REAL-WORLD OUTCOMES STUDY
Aug 11, 2026, 17:15 PM -
GLOBAL ECONOMIC BURDEN OF OBESITY IN ADULTS: AN UMBRELLA REVIEW OF SYSTEMATIC REVIEWS AND META-ANALYSES
Aug 11, 2026, 17:15 PM -
REAL-WORLD CLINICAL OUTCOMES AND CORRELATION OF RECURRENCE FREE SURVIVAL (RFS) AND DISTANT METASTASIS FREE SURVIVAL (DMFS) TO OVERALL SURVIVAL (OS) IN RESECTED STAGE IIB/C CUTANEOUS MELANOMA
Aug 11, 2026, 17:15 PM -
FORE SIGHTING THE ADOPTION OF ARTIFICIAL INTELLIGENCE-BASED DIAGNOSTIC APPLICATIONS IN ONCOLOGICAL IMAGING: A STRUCTURED EXPERT ELICITATION STUDY
Aug 11, 2026, 17:15 PM -
ESTIMATING THE PUBLIC HEALTH AND ECONOMIC BENEFIT ASSOCIATED WITH THE IMPLEMENTATION OF AN ADULT RSV NATIONAL IMMUNISATION PROGRAMME IN ENGLAND
Aug 11, 2026, 17:15 PM -
IMPACT OF VIRTUAL MATERNITY PROGRAM ENGAGEMENT ON NEONATAL OUTCOMES AND COSTS IN A COMMERCIAL POPULATION
Aug 11, 2026, 17:15 PM -
EARLY LUNG CANCER DETECTION USING ARTIFICIAL INTELLIGENCE ON CHEST X-RAYS: THE BUDGET IMPACT OF IMPLEMENTING INCIDENTAL PULMONARY NODULE DETECTION IN TURKIYE
Aug 11, 2026, 17:15 PM
